SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $14,002,000 | +144.7% | 146,179 | +311.6% | 2.11% | +367.3% |
| Q1 2018 | $5,721,000 | -73.4% | 35,518 | -72.8% | 0.45% | -67.4% |
| Q4 2017 | $21,497,000 | -11.2% | 130,516 | -72.5% | 1.39% | +18.4% |
| Q4 2016 | $24,220,000 | +3.7% | 474,339 | -6.4% | 1.17% | +9.4% |
| Q3 2016 | $23,347,000 | +58.1% | 506,990 | +3.4% | 1.07% | +31.8% |
| Q2 2016 | $14,767,000 | – | 490,100 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |